Bioxytran
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.32-0.00-0.02-0.28-146.42-11.65-6.00-9.78-22.43-4.70-12.38-146.42
Price/Sales ratio
6.460.060.060.48N/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-8.04-0.07-0.050.16-192.63-30.41-7.97-15.39-20.45-8.28-15.03-192.63
Price/Cash Flow ratio
-109.13-5.77-0.36-4.97-233.46-56.39-20.52-25.03-30.60-25.96-14.44-233.46
Price/Free Cash Flow ratio
-109.13-5.77-0.36-4.97-233.46-56.39-20.33-24.50-30.07-24.56-14.35-233.46
Price/Earnings Growth ratio
0.030.000.000.001.48-0.01-0.09-4.340.47-0.09-0.43-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
39.77%46.96%60.93%45.58%N/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-464.66%-817.88%-272.32%-162.54%N/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-488.68%-820.93%-282.66%-166.62%N/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-488.68%-820.93%-282.66%-166.62%N/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-4.91%-0.37%-3.65%-2.44%-0.13%-12.21%-47.66%4.03%7.27%N/A4.81%-0.13%
Return on Assets
-1188.96%-3762.59%-1348.44%-43.87%-814.08%-949.55%-1150.24%-3642.68%-664.24%-3109.60%-1077.96%-949.55%
Return On Equity
608.21%1075.78%239.76%-58.70%131.55%260.91%132.69%157.38%91.19%176.06%116.79%260.91%
Return on Capital Employed
578.31%1071.78%231.00%-57.26%95.29%204.11%65.35%133.44%64.81%122.76%106.01%95.29%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.08N/A
Quick Ratio
0.010.010.060.200.1349.280.130.020.080.000.0849.28
Cash ratio
0.010.010.030.080.130.160.010.020.080.000.080.16
Days of Sales Outstanding
N/AN/A14.2143.85N/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A23.7718.47N/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/A37.9862.33N/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
443.24244.94140.85N/AN/AN/AN/AN/A99.1673.04N/AN/A
Cash Conversion Cycle
-443.24-244.94-102.8762.33N/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.971.972.12N/A6.243.874.9317.795.8313.989.876.24
Debt Equity Ratio
-0.49-0.56-0.37N/A-1.00-1.06-0.56-0.76-0.80-0.79-1.11-1.06
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
-0.98-1.29-0.60N/A110.1616.46-1.32-3.32-4.03-3.80N/A16.46
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-8.59N/A
Cash Flow to Debt Ratio
-0.14-0.02-0.38N/A-0.81-0.50-0.68-0.79-0.83-0.40N/A-0.81
Company Equity Multiplier
-0.51-0.28-0.171.33-0.16-0.27-0.11-0.04-0.13-0.05-0.11-0.16
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.05-0.01-0.17-0.09N/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111111.001.021.011.051.001
Cash Flow Coverage Ratio
-0.14-0.02-0.38N/A-0.81-0.50-0.68-0.79-0.83-0.40N/A-0.81
Short Term Coverage Ratio
-0.14-0.02-0.38N/A-0.81-0.50-0.68-0.79-0.83-0.40-1.58-0.50
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A